Showing 8,461 - 8,480 results of 129,164 for search '(( i e decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 2.06s Refine Results
  1. 8461
  2. 8462
  3. 8463
  4. 8464
  5. 8465
  6. 8466
  7. 8467

    C5a concentration throughout the study period. by Dzenita Smailhodzic (659524)

    Published 2014
    “…<p>The C5a levels decreased significantly during the three months of zinc supplementation and returned to baseline level within 2 months after the cessation of zinc supplementation.…”
  8. 8468
  9. 8469
  10. 8470
  11. 8471
  12. 8472
  13. 8473

    Multiple homologs of 16p12.1 genes contribute to neurodevelopmental defects in <i>Drosophila melanogaster</i> and <i>X</i>. <i>laevis</i>. by Lucilla Pizzo (2735491)

    Published 2021
    “…Knockdown of <i>cdr2</i> (n = 54, two-tailed student’s t-test, *p = 7.75 ×10<sup>−4</sup>), <i>polr3e</i> (n = 37, *p = 1.97 ×10<sup>−13</sup>) and <i>mosmo</i> (n = 50, *p = 1.36 ×10<sup>−11</sup>) led to decreased face width, while knockdown of <i>polr3e</i> (*p = 3.29 ×10<sup>−16</sup>) and <i>mosmo</i> (*p = 1.47 ×10<sup>−8</sup>) led to decreased orofacial area. …”
  14. 8474
  15. 8475

    Neutralization of point mutants of B.1.351 and D614G spike-pseudotyped lentiviral particles by convalescent plasmas from B.1.351 and early 2020-infected individuals. by Allison J. Greaney (11046384)

    Published 2022
    “…<b>(B)</b> The fold-decrease in neutralization for samples shown in <b><a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1010248#ppat.1010248.g005" target="_blank">Fig 5</a></b>, with the addition of previously measured neutralization by samples from 6 early 2020 convalescent individuals collected approximately 100 days post-symptom onset [<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1010248#ppat.1010248.ref038" target="_blank">38</a>]. …”
  16. 8476
  17. 8477
  18. 8478
  19. 8479

    DataSheet_1_Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study.pdf by Haein Kim (4839594)

    Published 2023
    “…Background<p>Immune-evading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are emerging continuously. The clinical effectiveness of monoclonal antibody agents that exhibit decreased in vitro activity against SARS-CoV-2 variants needs to be elucidated.…”
  20. 8480